• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    11/6/24 6:06:19 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    pacs-20241106
    false000200118400020011842024-11-062024-11-06

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): November 6, 2024
    PACS GROUP, INC.
    (Exact name of registrant as specified in its charter)
    Delaware001-4201192-3144268
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification Number)
    262 N. University Ave.
    Farmington, Utah 84025
    (Address of principal executive offices, including Zip Code)
    Registrant’s telephone number, including area code: (801) 447-9829
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading
    Symbol(s)
    Name of each exchange
    on which registered
    Common Stock, $0.001 par value per sharePACSThe New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



    Item 2.02 Results of Operations and Financial Condition.
    On November 6, 2024, PACS Group, Inc. (the “Company”) issued a press release announcing certain preliminary operational metrics for the quarter ended September 30, 2024. The Company also announced that it will postpone its third quarter 2024 earnings release and conference call, originally scheduled for Thursday, November 7, 2024 at 5:00 p.m. Eastern Time. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.
    The information contained in this Current Report on Form 8-K (including Exhibit 99.1 hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
    Item 9.01 Financial Statements and Exhibits.
    Exhibit No.Description
    99.1
    Press Release of the Company dated November 6, 2024
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document)



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    PACS GROUP, INC.
    Date: November 6, 2024By:/s/ Derick Apt
    Derick Apt
    Chief Financial Officer

    Get the next $PACS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings